Astellas Pharma has submitted an NDA to Japan's Ministry of Health, Labour and Welfare seeking conditional approval of ACP.
Learn more about whether Glaukos Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback